Prednisolon 10 mg JENAPHARM

DRUG4 trials

Sponsors

Insel Gruppe AG, AbbVie Deutschland GmbH & Co. KG, Goethe University Frankfurt, Rheinische Friedrich-Wilhelms-Universitaet Bonn

Conditions

Focal cerebral arteriopathy and childhood stroke Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection.Giant Cell ArteritisInflammatory cardiovascular involvement due to COVID-19defined by Cardiovascular magnetic resonance imaging

Phase 3

High Dose Steroids in Children with Stroke and Unilateral Focal Arteriopathy: A Multicentre Randomized Controlled Trial

Not yet recruitingCTIS2022-500631-36-00

Insel Gruppe AGFocal cerebral arteriopathy and childhood stroke Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection.

Target: 45Updated: 2025-11-14

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis

CompletedCTIS2023-505476-29-00

AbbVie Deutschland GmbH & Co. KGGiant Cell Arteritis

Start: 2019-04-05End: 2025-02-24Target: 201Updated: 2024-10-28

Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)

Active, not recruitingCTIS2024-516463-84-00

Goethe University Frankfurtdefined by Cardiovascular magnetic resonance imaging, Inflammatory cardiovascular involvement due to COVID-19

Start: 2022-12-13Target: 280Updated: 2025-04-25

A Randomized, Double-Blind, Phase II Investigator Initiated Trial of Upadacitinib and Short Glucocorticoid Tapering in Giant Cell Arteritis

Not yet recruitingCTIS2025-523199-22-00

Rheinische Friedrich-Wilhelms-Universitaet BonnGiant Cell Arteritis

Target: 70Updated: 2026-10-02